Posttransplantation hypertension related to calcineurin inhibitors.
about
Pre-treatment considerations in childhood hypertension due to chronic kidney diseaseRegulatory T-cell therapy in transplantation: moving to the clinicDrug-induced blood pressure increase - recommendations for assessment in clinical and non-clinical studies.Neurotoxicity of immunosuppressive drugs.Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study.Conversion to sirolimus ameliorates cyclosporine-induced nephropathy in the rat: focus on serum, urine, gene, and protein renal expression biomarkersTransition from cyclosporine-induced renal dysfunction to nephrotoxicity in an in vivo rat model.Hypertension and renal dysfunction in long-term liver transplant recipients.Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.FK506 binding protein 12 deficiency in endothelial and hematopoietic cells decreases regulatory T cells and causes hypertension.Cardiorenal benefits of early versus late cyclosporine to sirolimus conversion in a rat model.Hepatobiliary Quiz Answers-17 (2016).Post-operative hypertension, a surrogate marker of the graft function and predictor of survival in living donor liver transplant recipients: A retrospective study.Long-term outcome after liver transplantation.Calcineurin inhibitor sparing with mycophenolate mofetil in liver transplantion: a systematic review of randomized controlled trials.Regulatory T cells: tolerance induction in solid organ transplantation.The Far Side of Vascular Injury: Nonconventional Vasoconstrictors, DNA-targeting Agents, and Agents Toxic to Vascular Smooth Muscle.Keys to long-term care of the liver transplant recipient.Lung Transplantation for Scleroderma-related Lung Disease.Synthetic pharmacotherapy for lupus nephritis.Curing Hepatitis C in Liver Transplant Recipients Is Associated with Changes in Immunosuppressant UsePregnancy after liver transplantation. How safe? A retrospective case-series study in a large tertiary hospital.Unique Considerations When Managing Hypertension in the Transplant Patient.Incidence and risk factors for herpes zoster in patients undergoing liver transplantation.Amlodipine-induced gingival overgrowth in a child after liver transplant.Vascular resistance and endothelial function in cyclosporine-treated lung transplant recipients.Protective effect of curcumin on cyclosporin A-induced endothelial dysfunction, antioxidant capacity, and oxidative damage.Association between calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients.Tacrolimus-related adverse effects in liver transplant recipients: its association with trough concentrations.Blood pressure elevation in long-term survivors of pediatric liver transplantation.Coronary event rates in liver transplant recipients reflect the increased prevalence of cardiovascular risk-factors.Regulatory T-Cell Augmentation or Interleukin-17 Inhibition Prevents Calcineurin Inhibitor-Induced Hypertension in Mice.High prevalence of renal dysfunction in children after liver transplantation: non-invasive diagnosis using a cystatin C-based equation.Cell Therapy in Organ Transplantation: Our Experience on the Clinical Translation of Regulatory T Cells.Long-term results after liver transplantation.Hypertension: The Neglected Complication of Transplantation
P2860
Q26777613-905F9371-D5BA-42BD-B143-13DD5477CDF4Q27025869-3D2D186F-608C-4667-ABB4-B8FD179DA5A7Q30395099-E49AAC90-A6C7-49E2-A198-07CB499BEF2CQ32031478-6363A000-0F1B-40DE-A9B4-7CF07ADBFA0DQ33394798-8D71654F-0D7C-4DCB-94DA-672AA3278959Q33746612-289B7F34-DD4B-4058-A752-9173DF7080B6Q33755928-EE2B09AD-29A7-4AA9-B86B-A9AD067846FDQ34426372-39375267-F94B-4AFC-B8DF-DCA5968CFDAEQ34646976-4902D5E0-049B-454B-87E0-28BC4BC1A782Q35024911-4E6E9F65-FE3C-47EA-A742-00DEC08ED075Q35975228-2A903EE2-6609-474B-AF11-181D46C2B06BQ36886795-DCF308F8-FC32-4A1F-BEE6-2FC3A6B569F0Q37137971-E093B137-1650-44BF-AED1-0B453CF4FA3CQ38002368-69B2C7CB-FD7B-4679-BB6C-205E34C7EA3AQ38027593-2ACD4AF5-5852-457C-A0DA-36F204BB81ECQ38557841-61C2E878-0B55-475D-ABAB-22C56DE265BCQ38583684-0B25EF88-C4E3-44ED-846F-CB1C7FE6E4A1Q38605687-6F1A33EA-C2CE-4647-B606-EEF37AE7499BQ39005017-C201B8C4-F242-440D-B861-87D094227B36Q39064602-8FD262CB-F8C2-425E-B4C7-58ACA49D1CC5Q39478255-1BB4F2E8-091E-4456-8CCE-E4DBE9B52402Q40124382-044ABC17-DAE5-4427-9181-C3CA6FB8871DQ40488379-FD2D1CE7-0DEC-4AA2-8537-2FC32E64CD62Q40707474-938BF973-7A12-45C1-8089-2366176513F6Q41629774-B61927F1-C0FE-4647-AE67-944E6BC42C11Q42503633-042C921F-EBB4-478B-9ABA-B461D6CFE683Q45272269-5E5FA9AF-9470-4A06-BBA0-B799485CDC90Q45363560-59C96B97-B44D-4B21-906C-FD13C97A682EQ45738416-77A75EEE-61E0-4A96-98F8-EDB285E7FAB2Q46403134-1B8BE628-2A65-4C2A-8C27-918A194D9366Q46594261-0A1CF48B-2501-49F7-9523-09A54DD76D6FQ50958283-293365F5-FFC2-4719-A389-6D68AF06E536Q51662920-60772B1F-A33E-4020-99BE-301DD8247AACQ52657146-18535184-FB02-4D28-81EF-0C9B34F6816EQ52922055-5A4C0AD5-30FC-447D-9193-3477843638FBQ58992876-9A9E5658-48F4-44AD-9627-C031048657A3
P2860
Posttransplantation hypertension related to calcineurin inhibitors.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Posttransplantation hypertension related to calcineurin inhibitors.
@ast
Posttransplantation hypertension related to calcineurin inhibitors.
@en
Posttransplantation hypertension related to calcineurin inhibitors.
@nl
type
label
Posttransplantation hypertension related to calcineurin inhibitors.
@ast
Posttransplantation hypertension related to calcineurin inhibitors.
@en
Posttransplantation hypertension related to calcineurin inhibitors.
@nl
prefLabel
Posttransplantation hypertension related to calcineurin inhibitors.
@ast
Posttransplantation hypertension related to calcineurin inhibitors.
@en
Posttransplantation hypertension related to calcineurin inhibitors.
@nl
P2093
P356
P1476
Posttransplantation hypertension related to calcineurin inhibitors.
@en
P2093
Augustine JE
Canzanello VJ
Schwartz L
P304
P356
10.1053/JLTS.2000.9737
P577
2000-09-01T00:00:00Z